Table 2.

Change from baseline to Week 12 in REVEAL 2.0 Risk Score in TRIUMPH cohort.

Study groupa	Baseline	Week 12
	Mean (SD)	Mean (SD) change from baseline	Mean difference (SE), p value
Inhaled TRE (n = 69)	7.38 (2.21)	–0.81 (1.87)	–0.90 (0.26), p = 0.0008
Placebo (n = 79)	7.34 (2.12)	0.09 (1.31)

SD: standard deviation; SE: standard error; TRE: treprostinil.

Note: If eGFR was not available, a score of +1 was given for this variable.

^ap Values were obtained from a two-sample t-test.